Cüneyt Zihni

Cüneyt Zihni

Auto-generated profile, based on publicly available information

Cüneyt Zihni

Department of Pediatric Cardiology, University of Health Sciences, İzmir Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, İzmir, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2021 in Echocardiography
Verified
Journal Article
Closed access
PDF file
TDTülay Demircan
Tülay Demircan
ÖKÖzgür Kizilca
Özgür Kizilca
NYNuh Yilmaz
Nuh Yilmaz
CZCüneyt Zihni
Cüneyt Zihni
MKMustafa Kir
Mustafa Kir
NÜNurettin Ünal
Nurettin Ünal

6 October 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
EDEser Dogan
Eser Dogan
MKMUSTAFA KARAÇELIK
MUSTAFA KARAÇELIK
MYMurat Muhtar Yilmazer
Murat Muhtar Yilmazer
TMTimur Meşe
Timur Meşe
CBCagatay Bilen
Cagatay Bilen
CKCeren Karahan
Ceren Karahan

20 August 2021 in The Journal of Pediatric Research
Verified
Journal Article
Closed access
SGSemra Gürsoy
Semra Gürsoy
FHFiliz Hazan
Filiz Hazan
CZCüneyt Zihni
Cüneyt Zihni
SASezer Acar
Sezer Acar
MYMurat Muhtar Yılmazer
Murat Muhtar Yılmazer
BÖBehzat Özkan
Behzat Özkan

6 March 2024 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
GVGamze Vuran
Gamze Vuran
MYMurat Muhtar Yılmazer
Murat Muhtar Yılmazer
EGEngin Gerçeker
Engin Gerçeker
CZCüneyt Zihni
Cüneyt Zihni
TMTimur Meşe
Timur Meşe
Background: The aim of this study is to evaluate the role of leukotriene B4, an inflammatory mediator, in the development of pulmonary hypertension in paediatric patients with CHD with left-right shunt.Methods: The study included forty patients with CHD with left-right shunts. Based on haemodynamic data obtained from cardiac diagnostic catheterisation, 25 patients who met the criteria for pulmonary arterial hypertension were included in the patient group. The control group comprised 15 patients who did not meet the criteria. The standard cardiac haemodynamic study was conducted. Leukotriene B4 levels were assessed in blood samples taken from both pulmonary arteries and peripheral veins.Results: The median age of patients with pulmonary arterial hypertension was 10 months (range: 3–168), while the median age of the control group was 50 months (range: 3–194). In the pulmonary hypertension group, the median pulmonary artery systolic/diastolic/mean pressures were 38/18/24 mmHg, compared to 26/10/18 mmHg in the control group. Leukotriene B4 levels in pulmonary artery blood samples were significantly higher in the pulmonary arterial hypertension group compared to the controls (p < 0.05). Peripheral leukotriene B4 levels were also elevated in the pulmonary arterial hypertension group in comparison to the control group, though the difference was not statistically significant.Conclusion: The discovery of elevated leukotriene B4 levels in pulmonary artery samples from paediatric patients with pulmonary arterial hypertension secondary to CHD with left-to-right shunt suggests that local inflammation may have a pathological role in the development of pulmonary arterial hypertension.

28 November 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
EGEngin Gercekler
Engin Gercekler
MYMurat Muhtar Yilmazer
Murat Muhtar Yilmazer
TMTimur Meşe
Timur Meşe
GVGamze Vuran
Gamze Vuran
CZCuneyt Zihni
Cuneyt Zihni
Pediatrics,cardiac catheterization,adverse event,risk score,validation

14 February 2021 in Gynecology Obstetrics & Reproductive Medicine
Verified
Journal Article
Open access
PDF file
RARuya Atesli
Ruya Atesli
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
EEEzgi Yangin Ergon
Ezgi Yangin Ergon
FKFerit Kulali
Ferit Kulali
OKOguz Han Kalkanli
Oguz Han Kalkanli
SCSebnem Calkavur
Sebnem Calkavur
Objective: Hemodynamically significant patent ductus arteriosus(hsPDA) is resulting in severe mortality and morbidity in infants with extremely low birth weight(ELBW). In our study, we aimed to evaluate the necessity of performing routine echocardiography(ECHO) in the first 72hours in ELBW infants.Study Design:This study was planned retrospectively and observationally.Between June2016 and December2018,36 patients diagnosed with hemodynamically significant PDA(hsPDA) who were hospitalized in the neonatal intensive care unit(NICU),with ≤28Gw or ≤1000g were included in this study.These babies were routinely performed ECHO for PDA between 24-72hours,although they were asymptomatic in the period from June2016 to December2017(n:23).Between January2018 and December2018, patients without PDA symptoms were expected to complete 72hours for routine PDA screening (n:13).The patients were divided into 2 groups as early ECHO group(EEG)(n=23) and late ECHO group (LEG)(n=13).In the presence of at least one of the clinical signs of systemic hypoperfusion and/or pulmonary hyperperfusion, symptomatic PDA was accepted and closure treatment was applied with ibuprofen(n: 23) or paracetamol(n: 5).While the two groups were compared in terms of demographic features,ECHO findings,and the state of taking closure therapy,patients receiving closure therapy were compared in terms of mortality and premature morbidity.Results:The average birth weight of 36 patients was 855.9(± 241.5)g, and the average week of birth was 26.4(± 2.1)Gw.It was observed that the two groups were similar in terms of demographic characteristics.Although the findings of ECHO and treatment rates were similar between the two groups,it was observed that the EEG had earlier closure treatment(p = 0.03). In patients receiving closure treatment, performing early(n:17)and late(n:11) echocardiography showed no statistical difference in the long-term results.Conclusion:Performing early ECHO without symptoms in infants with ELBW may provoke the clinician to give PDA closure treatment earlier. In infants with ELBW,unnecessary closure treatment can be prevented by closely monitoring the symptoms of PDA and performing ECHO when necessary.